Johnson & Johnson Receives Subpoenas On Marketing Of Risperdal, Topamax and Natrecor
This article was originally published in The Pink Sheet Daily
Subpoenas relate to investigations into sales and marketing practices by U.S. Attorneys in Philadelphia, Boston and San Francisco.
You may also be interested in...
Rep. Waxman is requesting information into the marketing of Zyprexa, Seroquel, Actiq and Fentora.
OPM appears to be conducting a wide-ranging investigation into mental health drug marketing. Forest, J&J and Wyeth have received subpoenas from the agency that oversees Federal Employees Health Benefits Program.
The ADC specialist could have a fourth cancer drug on the market this year and is preparing for its first commercial launch in Europe.